138 related articles for article (PubMed ID: 3277709)
1. Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
Mandelli F; Tribalto M; Avvisati G; Cantonetti M; Petrucci MT; Boccadoro M; Pileri A; Marmont F; Resegotti L; Lauta V
Cancer Treat Rev; 1988 Jan; 15 Suppl A():43-8. PubMed ID: 3277709
[No Abstract] [Full Text] [Related]
2. Interferons in the treatment of multiple myeloma.
Cooper MR; Welander CE
Cancer; 1987 Feb; 59(3 Suppl):594-600. PubMed ID: 3802025
[TBL] [Abstract][Full Text] [Related]
3. INTRON A (interferon alfa-2b): clinical overview.
Spiegel RJ
Cancer Treat Rev; 1985 Dec; 12 Suppl B():5-16. PubMed ID: 3914355
[No Abstract] [Full Text] [Related]
4. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
[TBL] [Abstract][Full Text] [Related]
5. Treatment of multiple myeloma with recombinant interferon alfa-2a.
Ohno R; Kimura K
Cancer; 1986 Apr; 57(8 Suppl):1685-8. PubMed ID: 3948139
[TBL] [Abstract][Full Text] [Related]
6. The use of interferon in the treatment of multiple myeloma.
Costanzi JJ; Pollard RB
Semin Oncol; 1987 Jun; 14(2 Suppl 2):24-8. PubMed ID: 3296211
[TBL] [Abstract][Full Text] [Related]
7. [Interferon in the treatment of multiple myeloma].
Kuzmits R; Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Flener R; Scheithauer W
Acta Med Austriaca; 1985; 12(5):135-8. PubMed ID: 3914174
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of interferon alfa-2b (intron-A): the Manchester experience.
Scarffe JH; Wagstaff J; Crowther D
Ann Ist Super Sanita; 1987; 23(4):777-8. PubMed ID: 3452285
[No Abstract] [Full Text] [Related]
9. Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A).
Alimena G; Morra E; Lazzarino M; Liberati AM; Montefusco E; Inveradi D; Bernasconi P; Mancini M; Grignani F; Bernasconi C
Cancer Treat Rev; 1988 Jan; 15 Suppl A():21-6. PubMed ID: 3277708
[No Abstract] [Full Text] [Related]
10. Interferons in the treatment of multiple myeloma.
Cooper MR
Semin Oncol; 1986 Sep; 13(3 Suppl 2):13-20. PubMed ID: 3764441
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
Cooper MR; Fefer A; Thompson J; Case DC; Kempf R; Sacher R; Neefe J; Bickers J; Scarffe JH; Spiegel RJ
Invest New Drugs; 1987; 5 Suppl():S41-6. PubMed ID: 3597002
[TBL] [Abstract][Full Text] [Related]
12. Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
Ludwig H; Cortelezzi A; Van Camp BG; Polli E; Scheithauer W; Kuzmits R; Linkesch W; Gisslinger H; Sinzinger H; Fritz E
Oncology; 1985; 42 Suppl 1():19-25. PubMed ID: 4080297
[TBL] [Abstract][Full Text] [Related]
13. Interferons in the management of multiple myeloma.
Cooper MR
Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
[No Abstract] [Full Text] [Related]
14. Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trial.
Ludwig H; Cortelezzi A; Scheithauer W; Van Camp BG; Kuzmits R; Fillet G; Peetermans M; Polli E; Flener R
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1111-6. PubMed ID: 3536528
[TBL] [Abstract][Full Text] [Related]
15. Interferon alfa-2b in the management of chronic granulocytic leukemia.
Bergsagel DE
Cancer Treat Rev; 1988 Jan; 15 Suppl A():15-20. PubMed ID: 3422593
[No Abstract] [Full Text] [Related]
16. Recombinant interferon alfa-2b in plaque-phase mycosis fungoides. Intralesional and low-dose intramuscular therapy.
Vonderheid EC; Thompson R; Smiles KA; Lattanand A
Arch Dermatol; 1987 Jun; 123(6):757-63. PubMed ID: 3579357
[TBL] [Abstract][Full Text] [Related]
17. Treatment of multiple myeloma with natural alpha-interferon.
Mellstedt H
Hematol Oncol; 1988; 6(2):187-92. PubMed ID: 3292377
[No Abstract] [Full Text] [Related]
18. Recombinant alpha-interferon as salvage therapy in multiple myeloma. A pilot study.
Jacobs P; Le Roux IM; Wood L; King HS
S Afr Med J; 1989 Aug; 76(3):100-2. PubMed ID: 2762938
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
Bergsagel DE; Haas RH; Messner HA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):29-34. PubMed ID: 3464099
[TBL] [Abstract][Full Text] [Related]
20. Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group study.
Gertz MA; Kalish LA; Kyle RA; Hahn RG; Tormey DC; Oken MM
Am J Clin Oncol; 1995 Dec; 18(6):475-80. PubMed ID: 8526187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
